Does tuberculosis threaten our ageing populations?
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The global population is ageing quickly and our understanding of age-related changes in the immune system suggest that the elderly will have less immunological protection from active tuberculosis (TB). DISCUSSION: Ongoing global surveillance of TB notifications shows increasing age of patients with active TB. This effect of age is compounded by changes to clinical manifestations of disease, confounding of diagnostic tests and increased rates of adverse reactions to antimicrobial treatment of TB. Future epidemiological surveillance, development of diagnostic tests and trials of treatment shortening should all include a focus on ageing people. More detailed surveillance of TB notifications in elderly people should be undertaken and carefully evaluated. Risk stratification will help target care for those in greatest need, particularly those with comorbidities or on immunosuppressive therapies. Novel diagnostics and treatment regimes should be designed specifically to be used in this cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The current evidence suggests that although the tuberculosis burden remains substantially high in children,7, 8 older age groups generally have the highest rates of tuberculosis mortality and incidence.9, 10”
From Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 (2024) · cites this paper as [10]
Experimental — accuracy not yet measuredIn the citing paper
“they do not have classical clinical features,65 which has been shown to delay diagnosis and treatment,17”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“Persistently raised levels of proinflammatory cytokines are evident in older people [24, 25] and in pulmonary macrophages of older mice [26].”
BackgroundFranceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087 · cited 1×
“Persistently raised levels of proinflammatory cytokines are evident in older people [24, 25] and in pulmonary macrophages of older mice [26].”
BackgroundJeon, C. Y., & Murray, M. B. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050152 · Cited by 1,486
Age-dependent dysregulation of innate immunity
Shaw, A. C., Goldstein, D. R., & Montgomery, R. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3547 · Cited by 1,061 · cited 1×
“These include reduced expression of innate immune receptors, reduced production of tumour necrosis factor (TNF) and reduced phagocytosis [18].”
BackgroundHost-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 767 · cited 1×
“The importance of well-calibrated mechanisms for regulation of inflammation to avoid or minimise the immunopathogenesis of TB are also increasingly recognised [21–23].”
BackgroundDixon, W. G., Hyrich, K. L., Watson, K. D., Lunt, M., Galloway, J., Ustianowski, A., & Symmons, D. P. M. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.118935 · Cited by 715
Aging of the innate immune system
Shaw, A. C., Joshi, S., Greenwood, H., Panda, A., & Lord, J. M. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.05.003 · Cited by 647 · cited 1×
“Ageing has significant effects on both the innate and adaptive immune system [5–7], which may contribute to the increased risk of infection.”
BackgroundTubach, F., Salmon, D., Ravaud, P., Allanore, Y., Goupille, P., Bréban, M., Pallot‐Prades, B., Pouplin, S., Sacchi, A., Chichemanian, R. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24632 · Cited by 632
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
Tobin, D. M., Roca, F. J., Oh, S. F., McFarland, R., Vickery, T. W., Ray, J. P., Ko, D. C., Zou, Y., Bang, N. D., Chau, T. T. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.023 · Cited by 580 · cited 1×
“The importance of well-calibrated mechanisms for regulation of inflammation to avoid or minimise the immunopathogenesis of TB are also increasingly recognised [21–23].”
Background
Research works printed but not linked: 2
- Organisation WH. World Population Aging 2013. In: United Nations. 2013.
- Organisation PAH. Tuberculosis in the Region of the Americas Regional Report 2011: Epidemiology, Control and Financing. In: Pan American Health Organisation, Washington DC. 2011.
Cited by
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V. L., Chu, H. T., Vongpradith, A., Novotney, A., LeGrand, K. E., Xu, Y. Y., Dai, X., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00007-0 · Cited by 146
“For example, older individuals are more likely to progress to active tuberculosis, they do not have classical clinical features, 65 which has been shown to delay diagnosis and treatment, 17 and they are more likely to have adverse reactions to treatment.”
The Impact of Immune System Aging on Infectious Diseases
Quiros-Roldan, E., Sottini, A., Natali, P. G., & Imberti, L. (2024) · Microorganisms · doi:10.3390/microorganisms12040775 · Cited by 133
“The interactions between MTB and the host immune system are complex and only partially clarified, but the concomitant overall senescence of both innate and adaptive immunity appears to play a major role [181–183].”
Tuberculosis in an Aging World
Olmo-Fontánez, A. M., & Turner, J. (2022) · Pathogens · doi:10.3390/pathogens11101101 · Cited by 109
“Specific for TB, numerous age-related comorbidities, such as diabetes, obesity, malnutrition, chronic respiratory diseases, cancer, and other underlying medical conditions, can result in an increased risk for developing active TB disease [7,8].”
BackgroundSingh, S. K., Kashyap, G. C., & Puri, P. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0627-3 · Cited by 79
Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people
Yew, W. W., Yoshiyama, T., Leung, C. C., & Chan, D. P. C. (2018) · Respirology · doi:10.1111/resp.13303 · Cited by 80
Metadata
- Authors
- Byng-Maddick, R., & Noursadeghi, M.
- Affiliations
- University College London (GB)
- Corresponding author
- Byng-Maddick, Rachel
- Venue
- BMC Infectious Diseases
- Published
- 2016-03-11
- Volume
- 16
- Issue
- 1
- Pages
- 119-119
- ISSN
- 1471-2334 (ISSN-L)
- PMC
- PMC4787032
- OpenAlex
- W2295027716
- Cited by
- 149
- References
- 65
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 17 · 2023: 19 · 2022: 26 · 2021: 18 · 2020: 19 · 2019: 11 · 2018: 7 · 2017: 7
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Arthritis Research UK (20131)
- National Institute for Health Research UCL Hospitals Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- tuberculosis, population aging, older adults, age-related immune changes, immunosenescence, tuberculosis epidemiology, tuberculosis surveillance, adverse drug reactions, treatment shortening, comorbidities, immunosuppressive therapy, risk stratification
- MeSH terms
- Age Factors, Aged, Health Services for the Aged, Humans, Risk Factors, Tuberculosis, Global Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does tuberculosis threaten our ageing populations? https://app.cochat.ai/papers/10.1186/s12879-016-1451-0
- The paper
- Byng-Maddick, R., & Noursadeghi, M. (2016). Does tuberculosis threaten our ageing populations? BMC Infectious Diseases. https://doi.org/10.1186/s12879-016-1451-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.